FCM Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,800
Closed -$145K 70
2017
Q1
$145K Hold
1,800
0.09% 65
2016
Q4
$128K Hold
1,800
0.08% 72
2016
Q3
$156K Hold
1,800
0.09% 66
2016
Q2
$156K Sell
1,800
-500
-22% -$40.4K 0.09% 59
2016
Q1
$173K Hold
2,300
0.09% 59
2015
Q4
$177K Hold
2,300
0.09% 61
2015
Q3
$154K Hold
2,300
0.08% 60
2015
Q2
$170K Hold
2,300
0.08% 62
2015
Q1
$179K Hold
2,300
0.09% 61
2014
Q4
$166K Hold
2,300
0.08% 61
2014
Q3
$142K Sell
2,300
-68,440
-97% -$4.35M 0.06% 62
2014
Q2
$4.51M Sell
70,740
-1,500
-2% -$91.1K 2.07% 14
2014
Q1
$4.45M Sell
72,240
-400
-0.6% -$23.3K 1.85% 16
2013
Q4
$4.17M Sell
72,640
-300
-0.4% -$17K 1.71% 18
2013
Q3
$3.88M Sell
72,940
-5,550
-7% -$299K 1.56% 18
2013
Q2
$4.04M Buy
+78,490
New +$3.88M 1.8% 17

Other funds holding MDT

FCM Investments's MDT Position: Q2 2017 in Review

FCM Investments sold out of Medtronic (MDT) in Q2 2017, closing a stake of 1,800 shares — an estimated $145K sold.

FCM Investments first reported a position in MDT in Q2 2013 and held it in 16 quarters. The position peaked at $4.51M in Q2 2014. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • FCM Investments reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
  • FCM Investments sold 1,800 Medtronic shares in Q2 2017, an estimated $145K.
  • FCM Investments first reported a position in Medtronic in Q2 2013 and held it in 16 quarters.
  • FCM Investments's Medtronic position peaked at $4.51M in Q2 2014.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on FCM Investments's 13F filing for Q2 2017, filed 28 Jul 2017.